Climb Bio appoints Susan Altschuller as CFO, grants 600,000 stock options

Climb Bio, Inc.

Appointed Susan Altschuller, Ph.D., MBA, as CFO and Treasurer effective Oct 1, 2025; previously CFO at Cerevel and ImmunoGen.
Base salary $510,000/year; eligible for annual bonus up to 40% of base.
Received option to purchase 600,000 shares under 2025 Inducement Plan; vesting 25% on one-year anniversary then monthly.
Board amended Inducement Plan to increase reserved shares from 1.25M to 2.0M.
Cindy Driscoll steps down as principal financial officer but continues as principal accounting officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.